Hepion Pharmaceuticals Inc

NASDAQ:HEPA   4:00:00 PM EDT
2.50
+0.18 (+7.76%)
4:47:58 PM EDT: $2.44 -0.06 (-2.40%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Hepion Pharmaceuticals Inc Stock, NASDAQ:HEPA

399 Thornall Street, 1st Floor, Edison, New Jersey 08837
United States of America
Phone: +1.732.902.4000
Number of Employees: 25

Description

Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate rencofilstat, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease. The company was founded on May 15, 2013 and is headquartered in Edison, NJ.